IRIS
TOMELLERI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 374
NA - Nord America 301
AS - Asia 273
AF - Africa 2
Totale 950
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 298
SE - Svezia 159
CN - Cina 133
IT - Italia 120
SG - Singapore 89
RU - Federazione Russa 47
PH - Filippine 20
DE - Germania 14
FI - Finlandia 14
IN - India 11
GB - Regno Unito 5
IE - Irlanda 4
IR - Iran 4
MK - Macedonia 4
CA - Canada 3
KR - Corea 3
TR - Turchia 3
ES - Italia 2
HK - Hong Kong 2
IL - Israele 2
JP - Giappone 2
MY - Malesia 2
AL - Albania 1
BE - Belgio 1
DZ - Algeria 1
ID - Indonesia 1
LT - Lituania 1
NL - Olanda 1
TG - Togo 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 950
Salva come PNG Salva come JPEG
Città #
Singapore 65
Shanghai 61
Ashburn 36
Lawrence 31
Princeton 31
New York 30
Boardman 29
Milan 27
Moscow 21
Helsinki 12
Makati City 9
Pune 9
Rome 9
Naples 8
Dallas 7
Guangzhou 7
Los Angeles 6
Shenzhen 6
Ancona 5
Verona 5
Vittoria 5
Beijing 4
Dublin 4
Goito 4
Jiaxing 4
Quezon City 4
Cabanatuan City 3
Osimo 3
Pisa 3
Santa Clara 3
Skopje 3
Taizhou 3
Ankara 2
Arnsberg 2
Barcelona 2
Castel Mella 2
Clifton 2
Erlangen 2
Falkenstein 2
Florence 2
Foshan 2
General Trias 2
Honcho 2
Hyderabad 2
Lappeenranta 2
London 2
Orani 2
Padova 2
Palermo 2
Petaling Jaya 2
Sala Baganza 2
Seattle 2
Toronto 2
Trento 2
Washington 2
York 2
Zhengzhou 2
Amsterdam 1
Arlington 1
Atlanta 1
Baoding 1
Brussels 1
Catania 1
Cesano Maderno 1
Giv‘atayim 1
Issogne 1
Jakarta 1
Jiujiang 1
Kassel 1
Lomé 1
Martina Franca 1
Nantong 1
Ottawa 1
Poggiomarino 1
Quanzhou 1
Sacramento 1
Sezze 1
Tashkent 1
Tel Aviv 1
Tirana 1
Trentola-Ducenta 1
Vaprio d'Adda 1
Weitang 1
Yangzhou 1
Zhuhai 1
Totale 535
Salva come PNG Salva come JPEG
Nome #
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 48
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 43
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 40
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 39
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 30
Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis 29
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 29
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 28
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 26
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 26
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 25
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 23
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 23
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 23
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 22
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience 22
Drug retention rates of biological agents in adult onset Still's disease 22
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 21
Clinically isolated aortitis successfully treated with methotrexate monotherapy 21
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use 20
An enlightening scan 20
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis 20
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease 20
Primary heart involvement in systemic sclerosis, from conventional to innovative targeted therapeutic strategies 20
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 19
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 19
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 19
Response to: 'Correspondence on Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: A monocentric survey' by Comarmond et al 18
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 18
Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series 17
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 16
Failure of first anti-TNF agent in Takayasu’s arteritis: To switch or to swap? 16
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 16
Successful use of cyclosporin A and interleukin-1 blocker combination therapy in VEXAS syndrome: a single-center case series 16
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic 15
LONG-TERM PATHOPHYSIOLOGIC AND PROGNOSTIC EVALUATION OF DIFFERENT DISEASE SUBSETS IN GIANT CELL ARTERITIS 14
Impact of Geographic Location on Diagnosis and Initial Management of Takayasu Arteritis: A Tale of Two Cohorts from Italy and India 14
Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: A monocentric survey 14
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction 14
Clinical and dermoscopic description of accelerated nodulosis after tocilizumab treatment for an isolated aortitis with coronary involvement 13
Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement 13
Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis 13
Large Vessel Vasculitis Affecting the Aorta and Its Branches in Relapsing Polychondritis: Case Series and Systematic Review of the Literature 12
Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients 12
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance 12
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients 11
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort 11
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 11
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 10
Potential acceptance of COVID-19 vaccine in rheumatological patients: A monocentric comparative survey 10
Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply 10
Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease 9
Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study 9
Efficacy of interleukin-1 blockade with anakinra in the management of post-COVID-19 steroid-dependent multisystem inflammatory syndrome: a case report 9
The target on B cells in Systemic Sclerosis: a “midsummer dream” to extinguish inflammation and prevent early disease progression to fibrosis 9
One year later: The case of tocilizumab in COVID-19 8
Myocardial infarction in giant cell arteritis: It is all a matter of balance 8
Multimodal chorioretinal imaging in erdheim-chester disease 7
Spontaneous coronary-artery dissection 4
Totale 1.086
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.812
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 0 0 0 0 0 12 1
2020/202121 1 0 2 3 0 4 3 3 0 0 3 2
2021/202264 0 0 23 17 2 4 6 2 4 3 0 3
2022/2023305 75 58 15 3 8 36 29 38 19 10 9 5
2023/2024403 11 30 52 36 34 59 33 44 3 7 15 79
2024/2025278 100 29 44 39 66 0 0 0 0 0 0 0
Totale 1.086